American biopharmaceutical manufacturing: Fueling economic growth now and for years to come

As the world has grappled with the current pandemic, there has been increased focus on biopharmaceutical manufacturing and its global supply chain. Many wondered whether the biopharmaceutical industry could ensure continued and uninterrupted supply of innovative medicines relied on by so many Americans, as well as develop and supply new treatments and vaccines to address the pandemic. We are nearly a year into this public health crisis, and the biopharmaceutical manufacturing industry has stepped up to help beat COVID-19 in more ways than one. Anew report from TEConomy Partners takes a closer look at what makes the U.S. biopharmaceutical manufacturing industry so globally competitive. While highlighting U.S. leadership, the report also makes clear the critical steps needed to secure that leadership: addressing the gaps in infrastructure investments, as well as investing in the growth of a STEM workforce.
Source: The Catalyst - Category: Pharmaceuticals Tags: Economic Impact Manufacturing STEM Coronavirus Source Type: news